Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1429-1429
Open Access | Times Cited: 22

Showing 22 citing articles:

Applying a biopsychosocial model to migraine: rationale and clinical implications
Chiara Rosignoli, Raffaele Ornello, Agnese Onofri, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 78
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 69
Serotonin receptors in epilepsy: Novel treatment targets?
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 40
Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1612-1612
Open Access | Times Cited: 38
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein
BioDrugs (2022) Vol. 36, Iss. 3, pp. 341-358
Open Access | Times Cited: 28
Herbal medicines for insomnia through regulating 5-hydroxytryptamine receptors: a systematic review
Haoran WANG, Yanqiu Gu, Rahman Khalid, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 7, pp. 483-498
Closed Access | Times Cited: 17
Real world considerations for newly approved CGRP receptor antagonists in migraine care
Damiana Scuteri, Paolo Tonin, Pierluigi Nicotera, et al.
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 3, pp. 221-230
Closed Access | Times Cited: 17
Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Unmet needs for migraine
Paolo Martelletti, Martina Curto
Current Medical Research and Opinion (2021) Vol. 37, Iss. 11, pp. 1957-1959
Closed Access | Times Cited: 8
Atogepant: an emerging treatment for migraine
Cecilia Rustichelli, Rossella Avallone, Anna Ferrari
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 6, pp. 653-662
Closed Access | Times Cited: 5
Hormonal therapies in migraine management: current perspectives on patient selection and risk management
Enrico Bentivegna, Michelangelo Luciani, Francesco Scarso, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 12, pp. 1347-1355
Closed Access | Times Cited: 6
Safety of drugs used for the treatment of migraine during pregnancy: a narrative review
Jessica A Spiteri, Gabrielle Camilleri, Carlo Piccinni, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 3, pp. 207-217
Closed Access | Times Cited: 2
Ditans: a new prospective for the therapy of migraine attack?
Giovanna Viticchi, Lorenzo Falsetti, Mauro Silvestrini, et al.
Neurological Sciences (2022) Vol. 43, Iss. 9, pp. 5709-5716
Closed Access | Times Cited: 4
CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine
Francesca Finelli, Alessia Catalano, Michele De Lisa, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 163-163
Open Access
A higher prevalence of migraine in patients with cardiac syndrome x compared to patients with cardiovascular disease and healthy control
Mehran Movahednia, Elham Ouspid, Shahin Abbaszadeh, et al.
Research Square (Research Square) (2024)
Open Access
New Migraine Drugs for Older Adults
Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, et al.
Drugs & Aging (2023) Vol. 40, Iss. 4, pp. 301-305
Closed Access | Times Cited: 1
Novel Pharmacological Targets of Migraine: An Overview
Eduardo Rivera‐Mancilla, Antoinette MaassenVanDenBrink
Headache (2022), pp. 1-17
Closed Access | Times Cited: 2
Headache Medicine Grand Challenge: Headache: A New Frontier, A New Challenge
Frederick G. Freitag
Frontiers in Pain Research (2021) Vol. 2
Open Access | Times Cited: 1
Self-medication: A Mechanistic Review of Common Drugs
Shiksha Kaushal, Vivek Sharma
International Journal of Pharmaceutical Sciences Review and Research (2023) Vol. 80, Iss. 02
Open Access
Ubrogepant
Martina Curto, Luana Lionetto
Headache (2022), pp. 43-50
Closed Access
Zavegepant
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, et al.
Headache (2022), pp. 67-72
Closed Access
Reaching the Nadir of Medication Overuse in Chronic Migraine
Dilara Onan, William Wells-Gatnik, Paolo Martelletti
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 22, pp. 14696-14696
Open Access
Page 1

Scroll to top